KalVista Pharmaceuticals Aktie
13,20
EUR
+0,40
EUR
+3,13
%
15,16
USD
-0,63
USD
-3,99
%
Werbung
KalVista Pharmaceuticals Aktie Analyse
| 20.03.19 | KalVista Pharmaceuticals Buy | Needham & Company, LLC | |
| 21.09.18 | KalVista Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 31.08.17 | KalVista Pharmaceuticals Buy | BTIG Research |
Werbung
Werbung